• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Federal Pharmaceutical Subsidiary's Two Eye Drops Approved for Market by National Drug Administration
10:02
Federal Pharmaceutical Obtains Approval for Moxifloxacin Hydrochloride Eye Drops
09:59
Nov26
Fed Pharma Zhongshan Branch's Cefoperazone Sodium and Sulbactam Sodium for Injection Passes Consistency Evaluation
09:12
Sep30
Federation Pharma's Innovative Drug UBT37034 Receives Clinical Trial Approval from National Medical Products Administration
08:38
Sep19
Zhongtai Securities Gives 'Buy' Rating to Fed Pharma
06:03
Sep17
CITIC Securities Initiates Coverage of FedPharma with a Strong Buy Rating
06:39

Schedules & Filings

Schedules
Filings
Oct15
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep26
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep25
Distribution Plan(CST)

Cash dividend 0.175 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08311
0.154
+71.11%
+0.064
02673
0.410
+36.67%
+0.110
01237
0.680
+36.00%
+0.180
01750
0.082
+30.16%
+0.019
00653
0.083
+29.69%
+0.019
01107
0.019
+26.67%
+0.004
01020
0.158
+26.40%
+0.033
01757
1.770
+25.53%
+0.360
01255
1.600
+21.21%
+0.280
02113
0.069
+21.05%
+0.012
View More